Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy.

AIM OF STUDY Nowadays diabetic nephropathy (DN) has become a serious problem. Astragalus membranaceus is a traditional herb used for thousands of years in China and East Asia for kidney disease. In modern medicine, Astragalus shows significant renal protective effect in DN. We aimed to systematically review the randomized and semi-randomized control trials to ascertain its role in the treatment of DN. MATERIALS AND METHODS PUBMED, MEDLINE, Chinese journal full-test database (CJFD), Chinese biological and medical database were searched by computer and manual searching. Two assessors independently reviewed each trial. 25 studies comprising 21 RCTs and 4 CCTs were involved including 1804 patients (945 in treatment group and 859 in control group). RESULTS AND CONCLUSIONS Astragalus injection had more therapeutic effect in DN patients including renal protective effect (BUN, SCr, CCr and urine protein) and systemic state improvement (serum albumin level) compared with the control group. ETHNOPHARMACOLOGICAL RELEVANCE This study investigates the effect of Astragalus in DN patients. It suggests that although of unknown bioactive ingredients and mechanism of renal protection, the role of Astragalus in the treatment of DN can be disclosed and of profound significance.

[1]  W. Cho,et al.  In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. , 2007, Journal of ethnopharmacology.

[2]  Fa-ming Wu,et al.  [A review of pharmacological study on Astragalus membranaceus (Fisch.) Bge]. , 2004, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[3]  B. Kasiske,et al.  Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Liu Zq,et al.  Effect of Astragalus injection on platelet function and plasma endothelin in patients with early stage diabetic nephropathy , 2001 .

[5]  Dingkun Gui,et al.  Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide. , 2008, Journal of ethnopharmacology.

[6]  S. Toda,et al.  Inhibitory effects of Astragali Radix, a crude drug in Oriental medicines, on lipid peroxidation and protein oxidative modification by copper. , 1999, Journal of ethnopharmacology.

[7]  Mao-hua Yu,et al.  Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[8]  Y. Jeon,et al.  Macrophage activation by polysaccharide isolated from Astragalus membranaceus. , 2005, International immunopharmacology.

[9]  Dingkun Gui,et al.  Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via alpha3beta1 integrin upregulation and integrin-linked kinase inhibition. , 2008, Biochemical pharmacology.

[10]  Ross Ward,et al.  United States Renal Data System , 2011 .

[11]  Jing-zi Li,et al.  Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. , 2004, Life sciences.

[12]  L. Stevens,et al.  Testing for chronic kidney disease: a position statement from the National Kidney Foundation. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  C. Mogensen,et al.  The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy , 1983, Diabetes.